Neoadjuvant immunotherapy for resectable hepatocellular carcinoma - Authors' reply

Lancet Gastroenterol Hepatol. 2022 Jun;7(6):505. doi: 10.1016/S2468-1253(22)00122-4.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Carcinoma, Hepatocellular* / pathology
  • Carcinoma, Hepatocellular* / therapy
  • Humans
  • Immunologic Factors
  • Immunotherapy
  • Liver Neoplasms* / pathology
  • Liver Neoplasms* / therapy
  • Neoadjuvant Therapy

Substances

  • Immunologic Factors